Related Experiment Video
Updated: May 4, 2026

08:04
Murine Fetal Echocardiography
Published on: February 15, 2013
17.2K
First-Trimester Cardiac Myxoma Diagnosed at 12 Weeks with Postmortem Validation
Büşra Tsakir1, Elif Ayan Avcı2, Gül Alkan Bülbül2
1Department of Perinatology, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey. busratsakir@hotmail.com.
Pediatric Cardiology
|May 2, 2026
Summary
This study reports the earliest diagnosis of a fetal cardiac myxoma at 12 weeks gestation. Despite being benign, this rare tumor caused rapid hemodynamic compromise, leading to pregnancy termination.
Area of Science:
- Cardiology
- Fetal Medicine
- Pathology
Background:
- Primary cardiac tumors are rare in fetuses, with rhabdomyomas being most common.
- Fetal cardiac myxomas are exceptionally rare, particularly with first-trimester diagnosis.
Purpose of the Study:
- To report the earliest documented case of fetal cardiac myxoma.
- To highlight the potential for rapid progression and severe hemodynamic compromise.
Main Methods:
- Fetal echocardiography at 12 weeks gestation identified a right atrial mass.
- Serial ultrasounds monitored tumor growth and fetal well-being.
- Postmortem examination and histopathology confirmed the diagnosis.
Main Results:
- A hyperechoic, pedunculated mass was diagnosed as a right atrial myxoma at 12 weeks gestation.
- Rapid tumor growth and significant hemodynamic compromise (pericardial effusion, reversed A-wave flow) were observed by 14 weeks.
- Histopathology confirmed cardiac myxoma with characteristic myxoid stroma and stellate cells.
Conclusions:
- Fetal cardiac myxomas can present early and progress rapidly, causing severe hemodynamic compromise even in the first trimester.
- Early fetal echocardiography is crucial for timely diagnosis and management.
- This case represents the earliest gestational age for diagnosis and confirmation of fetal cardiac myxoma.
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
557
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
557
Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805

